| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 174.48B | 167.05B | 166.70B | 141.10B | 52.90B | 74.53B |
| Gross Profit | 8.41B | 1.70B | 8.51B | 7.09B | -29.91B | -11.31B |
| EBITDA | 18.97B | 24.98B | 33.90B | 32.40B | -18.16B | 4.61B |
| Net Income | 1.97B | -1.74B | -237.31M | -1.05B | -45.18B | -18.83B |
Balance Sheet | ||||||
| Total Assets | 344.27B | 343.16B | 345.77B | 335.30B | 295.01B | 298.42B |
| Cash, Cash Equivalents and Short-Term Investments | 16.12B | 16.02B | 22.51B | 15.63B | 11.44B | 16.71B |
| Total Debt | 168.28B | 232.43B | 226.70B | 175.39B | 214.18B | 182.87B |
| Total Liabilities | 303.54B | 303.95B | 304.82B | 300.01B | 273.45B | 232.55B |
| Stockholders Equity | 43.99B | 42.53B | 45.15B | 37.23B | 23.61B | 61.40B |
Cash Flow | ||||||
| Free Cash Flow | 8.67B | 24.48B | 14.44B | 12.65B | -24.40B | 6.81B |
| Operating Cash Flow | 26.61B | 42.05B | 34.55B | 35.42B | -16.76B | 12.89B |
| Investing Cash Flow | -13.42B | -15.08B | -17.86B | -15.25B | -6.87B | -4.45B |
| Financing Cash Flow | -20.15B | -33.65B | -10.56B | -15.85B | 18.10B | 1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$73.10B | 2.86 | 19.38% | 5.38% | 11.88% | 10.90% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | HK$118.81B | 10.05 | 4.53% | ― | 2.95% | -247.29% | |
44 Neutral | HK$97.23B | 10.96 | 2.52% | ― | 5.99% | 44.57% | |
42 Neutral | HK$98.61B | 10.72 | 8.64% | ― | 4.68% | ― |